1h Free Analyst Time
The point of care diagnostics market is forecasted to grow by USD 14,645.04 mn during 2022-2027, accelerating at a CAGR of 10.65% during the forecast period. The report on the point of care diagnostics market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a growing geriatric population, increased focus on personalized medicine, and growing adoption of automated diagnostic devices in the healthcare industry.
The point of care diagnostics market is segmented as below:
By Product
- Hematology diagnostics
- Infectious disease diagnostics
- Rapid cardiovascular diagnostics
- Rapid coagulation diagnostics
- Others
By End-user
- Hospitals and clinics
- Homecare settings
- Clinical diagnostic laboratories
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the point of care diagnostics market covers the following areas:
- Point of care diagnostics market sizing
- Point of care diagnostics market forecast
- Point of care diagnostics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global point of care diagnostics market: Abaxis Inc, Abbott Laboratories, altona Diagnostics GmbH, Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson, Meridian Bioscience Inc., Nova Biomedical Corp., PerkinElmer Inc., PTS Diagnostics, QIAGEN NV, Sekisui Chemical Co. Ltd., Siemens AG, Trinity Biotech Plc, and Trivida Health Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is technological advances in diagnostics.`
According to the report, one of the major drivers for this market is the growing geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- altona Diagnostics GmbH
- Becton Dickinson and Co.
- bioMerieux SA
- Chembio Diagnostics Inc.
- Danaher Corp.
- DiaSorin SpA
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Services Inc.
- Meridian Bioscience Inc.
- Nova Biomedical Corp.
- Perkin Elmer Inc.
- QIAGEN NV
- Sekisui Chemical Co. Ltd.
- Siemens AG
- Sinocare Inc.
- Trinity Biotech Plc
- Trivida Health Inc.
- Zoetis Inc.
